BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26125810)

  • 21. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
    Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
    Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer.
    Cortés-Sarabia K; Alarcón-Romero LDC; Flores-Alfaro E; Illades-Aguiar B; Vences-Velázquez A; Mendoza-Catalán MÁ; Navarro-Tito N; Valdés J; Moreno-Godínez ME; Ortuño-Pineda C
    Biomed J; 2021 Dec; 44(6 Suppl 2):S171-S178. PubMed ID: 35491677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
    Li J; Jia H; Xie L; Wang X; He H; Lin Y; Hu L
    Gynecol Oncol; 2009 Jul; 114(1):89-93. PubMed ID: 19359031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer.
    Klenova EM; Morse HC; Ohlsson R; Lobanenkov VV
    Semin Cancer Biol; 2002 Oct; 12(5):399-414. PubMed ID: 12191639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood immune cell parameters in patients with high-grade squamous intraepithelial lesion (HSIL) and cervical cancer and their clinical value: a retrospective study.
    Wang L; Dong Y
    PeerJ; 2024; 12():e17499. PubMed ID: 38846752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.
    Martínez-Campos C; Bahena-Román M; Torres-Poveda K; Burguete-García AI; Madrid-Marina V
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2437-2445. PubMed ID: 28819773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology.
    Ho D; Drake TK; Smith-McCune KK; Darragh TM; Hwang LY; Wax A
    Int J Cancer; 2017 Mar; 140(6):1447-1456. PubMed ID: 27883177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
    Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB
    Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.
    Renaud S; Pugacheva EM; Delgado MD; Braunschweig R; Abdullaev Z; Loukinov D; Benhattar J; Lobanenkov V
    Nucleic Acids Res; 2007; 35(21):7372-88. PubMed ID: 17962299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis.
    Chen M; Zhang Y; Zheng PS
    PLoS One; 2017; 12(5):e0177171. PubMed ID: 28489874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
    Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR
    Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes.
    Hore TA; Deakin JE; Marshall Graves JA
    PLoS Genet; 2008 Aug; 4(8):e1000169. PubMed ID: 18769711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis.
    Wu MP; Tzeng CC; Wu LW; Huang KF; Chou CY
    Cancer J; 2004; 10(1):27-32. PubMed ID: 15000492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells.
    Rivero-Hinojosa S; Kang S; Lobanenkov VV; Zentner GE
    Sci Rep; 2017 Feb; 7():41279. PubMed ID: 28145452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic identification of key genes and pathways in the development of invasive cervical cancer.
    Niu G; Wang D; Pei Y; Sun L
    Gene; 2017 Jun; 618():28-41. PubMed ID: 28341182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-cadherin-160 C/A genotypes and cervical intraepithelial neoplasia.
    Cristina Rotar I; Muresan D; Elena Dumitras D; Popp Radu A; Maria Petrisor F; Stamatian F
    J BUON; 2016; 21(5):1184-1188. PubMed ID: 27837621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
    Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
    Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of CircEIF4G2 in Screening of Cervical Lesions.
    Mao Y; Zhang L; Li Y
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.
    Novak Kujundžić R; Grbeša I; Ivkić M; Krušlin B; Konjevoda P; Gall Trošelj K
    Pathol Oncol Res; 2014 Jul; 20(3):687-95. PubMed ID: 24563233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.